
Wockhardt Limited has informed the Exchange about press release dated 20-Mar-2022 titled Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom
Filed with NSE · · 4 pages · English
Wockhardt Limited has announced a collaboration with Serum Life Sciences UK for manufacturing multiple vaccines in the United Kingdom. This partnership aims to deliver a global vaccine program from a new facility in the UK, with a profit-sharing arrangement that could produce a significant number of vaccine doses annually. The collaboration is expected to create employment opportunities and enhance vaccine supply resilience.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Wockhardt Limited has informed the Exchange about press release dated 20-Mar-2022 titled Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom
Follow Wockhardt into a list and get an email when it puts out news.
Follow Wockhardt